Basel Medical Group Notified of Nasdaq Listing Non-Compliance

Basel Medical Group Ltd (NASDAQ: BMGL) announced Monday that it has received a notice from Nasdaq regarding an incomplete annual report filing. The company emphasized that this administrative matter is already being addressed and does not impact the current trading of its shares.

Under Nasdaq Listing Rule 5250(c)(1), Basel Medical has 60 calendar days to submit a compliance plan. If approved, the company could receive up to **180 additional days—potentially until May 18, 2026—**to fully resolve the filing deficiency.

Basel Medical said it is working proactively with its accounting, audit, and legal teams to finalize a rectification plan and ensure compliance is regained as quickly as possible.

The company reaffirmed its commitment to meeting all reporting requirements and maintaining its Nasdaq listing.